(Q48025647)

7 February 2018

title

Immunogenicity and booster efficacy of pre-exposure rabies vaccination (English)

1 reference

7 February 2018

0 references

C Strady

1

1 reference

7 February 2018

L Andreoletti

2

1 reference

7 February 2018

S Baumard

3

1 reference

7 February 2018

A Servettaz

4

1 reference

7 February 2018

R Jaussaud

5

1 reference

7 February 2018

A Strady

6

1 reference

7 February 2018

publication date

8 April 2009

1 reference

7 February 2018

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

7 February 2018

volume

103

1 reference

7 February 2018

issue

11

1 reference

7 February 2018

page(s)

1159-1164

1 reference

7 February 2018

An important date in rabies history.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Rabies update for travel medicine advisors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Intradermal pre-exposure rabies vaccine elicits long lasting immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Intradermal pre-exposure rabies immunisation in New Zealand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Associations between Human Leukocyte Antigen Homozygosity and Antibody Levels to Measles Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Immunogenicity study of abbreviated rabies preexposure vaccination schedules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Comparative study of the safety and protective value, in pre-exposure use, of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on Vero cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Purified Chick Embryo Cell Culture Rabies Vaccine: interchangeability with Human Diploid Cell Culture Rabies Vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Persistence of rabies antibody 5 years after pre-exposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

An experimental study on the endurance of immunologic memory of intradermal micro-injection with rabies vaccine and boosting immune effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

Booster effect of a new chromatographically purified Vero-cell rabies vaccine (CPRV): immunogenicity and safety of a single or double injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.03.007

10.1016/J.TRSTMH.2009.03.007

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

release_56slhjamjrhijppmqoduydn3i4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/56slhjamjrhijppmqoduydn3i4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

7 February 2018